RATIONALE: Mechanical ventilation (MV) is an indispensable therapy for critically ill patients with acute lung injury and the adult respiratory distress syndrome. However, the mechanisms by which conventional MV induces lung injury remain unclear. OBJECTIVES: We hypothesized that disruption of the gene encoding Nrf2, a transcription factor that regulates the induction of several antioxidant enzymes, enhances susceptibility to ventilator-induced lung injury (VILI) and that antioxidant supplementation attenuates this effect. METHODS: To test our hypothesis and to examine the relevance of oxidative stress in VILI, we assessed lung injury and inflammatory responses in Nrf2-deficient (Nrf2(-/-)) mice and wild-type (Nrf2(+/+)) mice after an acute (2-h) injurious model of MV with or without administration of antioxidant. MEASUREMENTS AND MAIN RESULTS: Nrf2(-/-) mice displayed greater levels of lung alveolar and vascular permeability and inflammatory responses to MV as compared with Nrf2(+/+) mice. Nrf2 deficiency enhances the levels of several proinflammatory cytokines implicated in the pathogenesis of VILI. We found diminished levels of critical antioxidant enzymes and redox imbalance by MV in the lungs of Nrf2(-/-) mice; however, antioxidant supplementation to Nrf2(-/-) mice remarkably attenuated VILI. When subjected to a clinically relevant prolong period of MV, Nrf2(-/-) mice displayed greater levels of VILI than Nrf2(+/+) mice. Expression profiling revealed lack of induction of several VILI genes, stress response and solute carrier proteins, and phosphatases in Nrf2(-/-) mice. CONCLUSIONS: Our data demonstrate for the first time a critical role for Nrf2 in VILI, which confers protection against cellular responses induced by MV by modulating oxidative stress.
RATIONALE: Mechanical ventilation (MV) is an indispensable therapy for critically illpatients with acute lung injury and the adult respiratory distress syndrome. However, the mechanisms by which conventional MV induces lung injury remain unclear. OBJECTIVES: We hypothesized that disruption of the gene encoding Nrf2, a transcription factor that regulates the induction of several antioxidant enzymes, enhances susceptibility to ventilator-induced lung injury (VILI) and that antioxidant supplementation attenuates this effect. METHODS: To test our hypothesis and to examine the relevance of oxidative stress in VILI, we assessed lung injury and inflammatory responses in Nrf2-deficient (Nrf2(-/-)) mice and wild-type (Nrf2(+/+)) mice after an acute (2-h) injurious model of MV with or without administration of antioxidant. MEASUREMENTS AND MAIN RESULTS:Nrf2(-/-) mice displayed greater levels of lung alveolar and vascular permeability and inflammatory responses to MV as compared with Nrf2(+/+) mice. Nrf2 deficiency enhances the levels of several proinflammatory cytokines implicated in the pathogenesis of VILI. We found diminished levels of critical antioxidant enzymes and redox imbalance by MV in the lungs of Nrf2(-/-) mice; however, antioxidant supplementation to Nrf2(-/-) mice remarkably attenuated VILI. When subjected to a clinically relevant prolong period of MV, Nrf2(-/-) mice displayed greater levels of VILI than Nrf2(+/+) mice. Expression profiling revealed lack of induction of several VILI genes, stress response and solute carrier proteins, and phosphatases in Nrf2(-/-) mice. CONCLUSIONS: Our data demonstrate for the first time a critical role for Nrf2 in VILI, which confers protection against cellular responses induced by MV by modulating oxidative stress.
Authors: Jay M Steinberg; Henry J Schiller; Jeffrey M Halter; Louis A Gatto; Hsi-Ming Lee; Lucio A Pavone; Gary F Nieman Journal: Am J Respir Crit Care Med Date: 2004-01-01 Impact factor: 21.405
Authors: William A Altemeier; Gustavo Matute-Bello; Charles W Frevert; Yasunobu Kawata; Osamu Kajikawa; Thomas R Martin; Robb W Glenny Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-05-14 Impact factor: 5.464
Authors: Franz J Wiedermann; Andreas J Mayr; Petra Hobisch-Hagen; Dietmar Fuchs; Wolfgang Schobersberger Journal: J Interferon Cytokine Res Date: 2003-12 Impact factor: 2.607
Authors: Ian B Copland; Brian P Kavanagh; Doreen Engelberts; Colin McKerlie; Jaques Belik; Martin Post Journal: Am J Respir Crit Care Med Date: 2003-06-19 Impact factor: 21.405
Authors: Xinqi Peng; Paul M Hassoun; Saad Sammani; Bryan J McVerry; Melissa J Burne; Hamid Rabb; David Pearse; Rubin M Tuder; Joe G N Garcia Journal: Am J Respir Crit Care Med Date: 2004-03-12 Impact factor: 21.405
Authors: Endre Kiss-Toth; Stephanie M Bagstaff; Hye Y Sung; Veronika Jozsa; Clare Dempsey; Jim C Caunt; Kevin M Oxley; David H Wyllie; Timea Polgar; Mary Harte; Luke A J O'neill; Eva E Qwarnstrom; Steven K Dower Journal: J Biol Chem Date: 2004-08-06 Impact factor: 5.157
Authors: Dmitry N Grigoryev; Shwu-Fan Ma; Rafael A Irizarry; Shui Qing Ye; John Quackenbush; Joe G N Garcia Journal: Genome Biol Date: 2004-04-27 Impact factor: 13.583
Authors: Anne Le; Rachel Damico; Mahendra Damarla; Adel Boueiz; Hyun Hae Pae; Jarrett Skirball; Emile Hasan; Xinqi Peng; Alan Chesley; Michael T Crow; Sekhar P Reddy; Rubin M Tuder; Paul M Hassoun Journal: J Appl Physiol (1985) Date: 2008-07-31
Authors: Adrian Doroszko; Thomas S Hurst; Dorota Polewicz; Jolanta Sawicka; Justyna Fert-Bober; David H Johnson; Grzegorz Sawicki Journal: Proteome Sci Date: 2010-01-29 Impact factor: 2.480
Authors: Holger C Müller; Katharina Hellwig; Simone Rosseau; Thomas Tschernig; Andreas Schmiedl; Birgitt Gutbier; Bernd Schmeck; Stefan Hippenstiel; Harm Peters; Lars Morawietz; Norbert Suttorp; Martin Witzenrath Journal: Crit Care Date: 2010-07-30 Impact factor: 9.097